Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
32397 | 139 | 30.7 | 54% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
17 | 4 | REPRODUCTIVE BIOLOGY//OBSTETRICS & GYNECOLOGY//VETERINARY SCIENCES | 563730 |
193 | 3 | PREECLAMPSIA//OBSTETRICS & GYNECOLOGY//REPRODUCTIVE BIOLOGY | 54114 |
1103 | 2 | ENDOMETRIUM//REPRODUCTIVE BIOLOGY//IMPLANTATION | 9797 |
32397 | 1 | TYPE II H 3ESTRADIOL BINDING SITES//TYPE II SITES//GYNAECOL LARGO A GEMELLI 8 | 139 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TYPE II H 3ESTRADIOL BINDING SITES | authKW | 878721 | 3% | 100% | 4 |
2 | TYPE II SITES | authKW | 659041 | 2% | 100% | 3 |
3 | GYNAECOL LARGO A GEMELLI 8 | address | 439360 | 1% | 100% | 2 |
4 | METHYL P HYDROXYPHENYLLACTATE | authKW | 439360 | 1% | 100% | 2 |
5 | METHYL P HYDROXYPHENYLLACTATE MEHPLA | authKW | 439360 | 1% | 100% | 2 |
6 | TYPE II ESTROGEN RECEPTORS | authKW | 439360 | 1% | 100% | 2 |
7 | TYPE II ESTROGEN BINDING SITES | authKW | 390538 | 3% | 44% | 4 |
8 | ESTRADIOL BINDING | authKW | 329517 | 2% | 50% | 3 |
9 | AND P53 | authKW | 219680 | 1% | 100% | 1 |
10 | AND PLA2 GENE EXPRESSION | authKW | 219680 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 1148 | 35% | 0% | 49 |
2 | Biochemistry & Molecular Biology | 292 | 40% | 0% | 55 |
3 | Oncology | 262 | 24% | 0% | 33 |
4 | Materials Science, Biomaterials | 19 | 2% | 0% | 3 |
5 | Biophysics | 16 | 5% | 0% | 7 |
6 | Toxicology | 12 | 4% | 0% | 5 |
7 | Cell Biology | 10 | 6% | 0% | 9 |
8 | Materials Science, Composites | 10 | 1% | 0% | 2 |
9 | Social Sciences, Interdisciplinary | 7 | 1% | 0% | 2 |
10 | Medical Laboratory Technology | 7 | 1% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GYNAECOL LARGO A GEMELLI 8 | 439360 | 1% | 100% | 2 |
2 | GYNECOL ANTINEOPLAST PHARMACOL ZENECA | 219680 | 1% | 100% | 1 |
3 | GYNECOL LARGO A GEMELLI | 219680 | 1% | 100% | 1 |
4 | OBSTET GYNECOL CLIN HISTOL | 219680 | 1% | 100% | 1 |
5 | SEMIOT MED EMATOL | 219680 | 1% | 100% | 1 |
6 | ZENECA ANTINEOPLAST PHARMACOL GYNECOL | 219680 | 1% | 100% | 1 |
7 | METAB MASS SPE OMETRY IL | 73223 | 1% | 17% | 2 |
8 | GYNECOL LARGO A GEMELLI 8 | 62762 | 1% | 14% | 2 |
9 | MED MASS SPE OMETRY IL | 31381 | 1% | 14% | 1 |
10 | IST OSTET GINECOL | 15690 | 1% | 7% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 14078 | 17% | 0% | 24 |
2 | JOURNAL OF RECEPTOR RESEARCH | 6042 | 3% | 1% | 4 |
3 | STEROIDS | 3236 | 6% | 0% | 8 |
4 | CELLS AND MATERIALS | 1091 | 1% | 0% | 1 |
5 | EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY | 793 | 1% | 0% | 2 |
6 | CURRENT CONTENTS/AGRICULTURE BIOLOGY & ENVIRONMENTAL SCIENCES | 707 | 1% | 0% | 1 |
7 | INTERNATIONAL JOURNAL OF ONCOLOGY | 570 | 4% | 0% | 5 |
8 | VOPROSY ONKOLOGII | 562 | 1% | 0% | 2 |
9 | ENVIRONMENTAL HEALTH PERSPECTIVES | 390 | 3% | 0% | 4 |
10 | CURRENT CONTENTS/LIFE SCIENCES | 355 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TYPE II H 3ESTRADIOL BINDING SITES | 878721 | 3% | 100% | 4 | Search TYPE+II+H+3ESTRADIOL+BINDING+SITES | Search TYPE+II+H+3ESTRADIOL+BINDING+SITES |
2 | TYPE II SITES | 659041 | 2% | 100% | 3 | Search TYPE+II+SITES | Search TYPE+II+SITES |
3 | METHYL P HYDROXYPHENYLLACTATE | 439360 | 1% | 100% | 2 | Search METHYL+P+HYDROXYPHENYLLACTATE | Search METHYL+P+HYDROXYPHENYLLACTATE |
4 | METHYL P HYDROXYPHENYLLACTATE MEHPLA | 439360 | 1% | 100% | 2 | Search METHYL+P+HYDROXYPHENYLLACTATE+MEHPLA | Search METHYL+P+HYDROXYPHENYLLACTATE+MEHPLA |
5 | TYPE II ESTROGEN RECEPTORS | 439360 | 1% | 100% | 2 | Search TYPE+II+ESTROGEN+RECEPTORS | Search TYPE+II+ESTROGEN+RECEPTORS |
6 | TYPE II ESTROGEN BINDING SITES | 390538 | 3% | 44% | 4 | Search TYPE+II+ESTROGEN+BINDING+SITES | Search TYPE+II+ESTROGEN+BINDING+SITES |
7 | ESTRADIOL BINDING | 329517 | 2% | 50% | 3 | Search ESTRADIOL+BINDING | Search ESTRADIOL+BINDING |
8 | AND P53 | 219680 | 1% | 100% | 1 | Search AND+P53 | Search AND+P53 |
9 | AND PLA2 GENE EXPRESSION | 219680 | 1% | 100% | 1 | Search AND+PLA2+GENE+EXPRESSION | Search AND+PLA2+GENE+EXPRESSION |
10 | BDHPC | 219680 | 1% | 100% | 1 | Search BDHPC | Search BDHPC |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MARKAVERICH, BM , ALEJANDRO, MA , (1998) TYPE II [H-3]ESTRADIOL BINDING SITE ANTAGONISTS: INHIBITION OF NORMAL AND MALIGNANT PROSTATE CELL GROWTH AND PROLIFERATION.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 12. ISSUE 5. P. 1127 -1135 | 33 | 75% | 11 |
2 | MARKAVERICH, BM , SHOULARS, K , ALEJANDRO, MA , (2006) NUCLEAR TYPE II[H-3]ESTRADIOL BINDING SITE LIGANDS: INHIBITION OF ER-POSITIVE AND ER-NEGATIVE CELL PROLIFERATION AND C-MYC AND CYCLIN D1 GENE EXPRESSION.STEROIDS. VOL. 71. ISSUE 10. P. 865-874 | 28 | 68% | 2 |
3 | MARKAVERICH, BM , SHOULARS, K , BROWN, MAT , (2001) PURIFICATION AND CHARACTERIZATION OF NUCLEAR TYPE II[H-3]ESTRADIOL BINDING SITES FROM THE RAT UTERUS: COVALENT LABELING WITH [H-3]LUTEOLIN.STEROIDS. VOL. 66. ISSUE 9. P. 707 -719 | 27 | 69% | 11 |
4 | SHOULARS, K , RODRIGUEZ, MA , THOMPSON, T , MARKAVERICH, BM , (2010) REGULATION OF CELL CYCLE AND RNA TRANSCRIPTION GENES IDENTIFIED BY MICROARRAY ANALYSIS OF PC-3 HUMAN PROSTATE CANCER CELLS TREATED WITH LUTEOLIN.JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. VOL. 118. ISSUE 1-2. P. 41-50 | 28 | 47% | 4 |
5 | SHOULARS, K , RODRIGUEZ, MA , CROWLEY, J , TURK, J , THOMPSON, T , MARKAVERICH, BM , (2006) RECONSTITUTION OF THE TYPE II[H-3]ESTRADIOL BINDING SITE WITH RECOMBINANT HISTONE H4.JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. VOL. 99. ISSUE 1. P. 1-8 | 19 | 68% | 2 |
6 | MARKAVERICH, BM , ALEJANDRO, MA , (1997) BIOFLAVONOIDS, TYPE II [H-3]ESTRADIOL BINDING SITES AND PROSTATIC CANCER CELL PROLIFERATION.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 11. ISSUE 6. P. 1311-1319 | 24 | 65% | 4 |
7 | SHOULARS, K , BROWN, T , ALEJANDRO, MA , CROWLEY, J , MARKAVERICH, BM , (2002) IDENTIFICATION OF NUCLEAR TYPE II[H-3]ESTRADIOL BINDING SITES AS HISTONE H4.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 296. ISSUE 5. P. 1083 -1090 | 28 | 46% | 10 |
8 | MARKAVERICH, BM , GREGORY, RR , (1993) PRELIMINARY ASSESSMENT OF LUTEOLIN AS AN AFFINITY LIGAND FOR TYPE-II ESTROGEN-BINDING SITES IN RAT UTERINE NUCLEAR EXTRACTS.STEROIDS. VOL. 58. ISSUE 6. P. 268-274 | 19 | 83% | 17 |
9 | MARKAVERICH, BM , VIJJESWARAPU, M , SHOULARS, K , RODRIGUEZ, M , (2010) LUTEOLIN AND GEFITINIB REGULATION OF EGF SIGNALING PATHWAY AND CELL CYCLE PATHWAY GENES IN PC-3 HUMAN PROSTATE CANCER CELLS.JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY. VOL. 122. ISSUE 4. P. 219 -231 | 17 | 45% | 11 |
10 | CARBONE, A , SERRA, FG , FERRANDINA, G , SCAMBIA, G , TERRIBILE, D , BELLANTONE, R , PIANTELLI, M , RANELLETTI, FO , (1997) METHYL-P-HYDROXYPHENYLLACTATE-ESTERASE ACTIVITY IN BREAST CANCER: A POTENTIALLY NEW PROGNOSTIC FACTOR IN SHORT-TERM FOLLOW-UP.CANCER RESEARCH. VOL. 57. ISSUE 23. P. 5406-5409 | 17 | 68% | 0 |
Classes with closest relation at Level 1 |